Home › NDC Lookup › RxCUI directory › RxCUI 311486

Meloxicam 7.5 MG Oral Tablet — RxCUI 311486

RxNorm drug concept · Semantic clinical drug
RxCUI 311486 Semantic clinical drug · SCD ● Current RxNorm concept 89 FDA products 336 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI311486
Official nameMeloxicam 7.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped89
Package NDCs mapped336
Reported Medicaid activity (SDUD)3,309,965 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Meloxicam: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Meloxicam is primarily used to relieve pain and inflammation caused by osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis in kids. There are also two IV versio...
  • What exactly is meloxicam used for — is it just for arthritis?
  • Good news — you can take oral meloxicam with or without food, so it fits into your routine however works best for you. If your stomach tends to be sensitive, taking it with a littl...
  • Should I take meloxicam with food, or does it not matter?
📖 Read our full Meloxicam guide →

🕸️ Concept Web — How Meloxicam 7.5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Meloxicam 7.5 MG Oral Tablet RxCUI 311486

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Meloxicam 41493
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Mobic 152699
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Meloxicam Oral Tablet 372754
    • Meloxicam Oral Product 1165678
    • Meloxicam Pill 1165679
    • Meloxicam Oral Tablet [Mobic] 368154
    • Mobic Oral Product 1181062
    • Mobic Pill 1181063
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Meloxicam 7.5 MG 323968
    • Meloxicam 7.5 MG Oral Tablet [Mobic] 152697
    • Meloxicam 7.5 MG [Mobic] 565025

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Meloxicam 7.5 MG SCDC · 323968
  • Meloxicam Oral Tablet SCDF · 372754
  • Meloxicam Oral Product SCDG · 1165678
  • Meloxicam Pill SCDG · 1165679

Brand-Name Concepts

  • Meloxicam 7.5 MG Oral Tablet [Mobic] SBD · 152697
  • Meloxicam 7.5 MG [Mobic] SBDC · 565025
  • Meloxicam Oral Tablet [Mobic] SBDF · 368154
  • Mobic Oral Product SBDG · 1181062
  • Mobic Pill SBDG · 1181063
  • Mobic BN · 152699

📦 FDA Products & Package NDCs

89 products · 336 package NDCs
336 package NDCs map to RxCUI 311486 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72789-0402-90 90 TABLET in 1 BOTTLE, PLASTIC (72789-402-90) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2024-05-30
72789-0402-95 1000 TABLET in 1 BOTTLE, PLASTIC (72789-402-95) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2024-05-30
72789-0403-07 7 TABLET in 1 BOTTLE, PLASTIC (72789-403-07) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2025-12-19
72789-0403-30 30 TABLET in 1 BOTTLE, PLASTIC (72789-403-30) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2024-08-22
72789-0403-60 60 TABLET in 1 BOTTLE, PLASTIC (72789-403-60) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2025-01-03
72789-0403-90 90 TABLET in 1 BOTTLE, PLASTIC (72789-403-90) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2024-05-30
72789-0403-95 1000 TABLET in 1 BOTTLE, PLASTIC (72789-403-95) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2024-05-30
72789-0446-14 14 TABLET in 1 BOTTLE, PLASTIC (72789-446-14) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2024-10-30
72789-0447-14 14 TABLET in 1 BOTTLE, PLASTIC (72789-447-14) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2025-01-03
72789-0447-15 15 TABLET in 1 BOTTLE, PLASTIC (72789-447-15) MELOXICAM PD-Rx Pharmaceuticals, Inc. 2024-10-30
72865-0137-01 100 TABLET in 1 BOTTLE (72865-137-01) Meloxicam XLCare Pharmaceuticals, Inc. 2020-02-17
72865-0137-10 1000 TABLET in 1 BOTTLE (72865-137-10) Meloxicam XLCare Pharmaceuticals, Inc. 2020-02-17
72865-0137-90 90 TABLET in 1 BOTTLE (72865-137-90) Meloxicam XLCare Pharmaceuticals, Inc. 2020-02-17
72865-0138-01 100 TABLET in 1 BOTTLE (72865-138-01) Meloxicam XLCare Pharmaceuticals, Inc. 2020-02-17
72865-0138-10 1000 TABLET in 1 BOTTLE (72865-138-10) Meloxicam XLCare Pharmaceuticals, Inc. 2020-02-17
72865-0138-90 90 TABLET in 1 BOTTLE (72865-138-90) Meloxicam XLCare Pharmaceuticals, Inc. 2020-02-17
72865-0332-01 100 TABLET in 1 BOTTLE (72865-332-01) MELOXICAM XLCare Pharmaceuticals, Inc. 2025-12-12
72865-0332-10 1000 TABLET in 1 BOTTLE (72865-332-10) MELOXICAM XLCare Pharmaceuticals, Inc. 2025-12-12
72865-0332-90 90 TABLET in 1 BOTTLE (72865-332-90) MELOXICAM XLCare Pharmaceuticals, Inc. 2025-12-12
72865-0333-01 100 TABLET in 1 BOTTLE (72865-333-01) MELOXICAM XLCare Pharmaceuticals, Inc. 2025-12-12
72865-0333-10 1000 TABLET in 1 BOTTLE (72865-333-10) MELOXICAM XLCare Pharmaceuticals, Inc. 2025-12-12
72865-0333-90 90 TABLET in 1 BOTTLE (72865-333-90) MELOXICAM XLCare Pharmaceuticals, Inc. 2025-12-12
76282-0152-01 100 TABLET in 1 BOTTLE (76282-152-01) Meloxicam Exelan Pharmaceuticals Inc. 2015-04-14
76282-0152-05 500 TABLET in 1 BOTTLE (76282-152-05) Meloxicam Exelan Pharmaceuticals Inc. 2015-04-14
76282-0152-10 1000 TABLET in 1 BOTTLE (76282-152-10) Meloxicam Exelan Pharmaceuticals Inc. 2015-04-14
76282-0152-30 30 TABLET in 1 BOTTLE (76282-152-30) Meloxicam Exelan Pharmaceuticals Inc. 2015-04-14
76282-0153-01 100 TABLET in 1 BOTTLE (76282-153-01) Meloxicam Exelan Pharmaceuticals Inc. 2015-04-14
76282-0153-05 500 TABLET in 1 BOTTLE (76282-153-05) Meloxicam Exelan Pharmaceuticals Inc. 2015-04-14
76282-0153-10 1000 TABLET in 1 BOTTLE (76282-153-10) Meloxicam Exelan Pharmaceuticals Inc. 2015-04-14
76282-0153-30 30 TABLET in 1 BOTTLE (76282-153-30) Meloxicam Exelan Pharmaceuticals Inc. 2015-04-14
76420-0043-15 15 TABLET in 1 BOTTLE (76420-043-15) meloxicam Asclemed USA, Inc. 2022-10-04
76420-0043-30 30 TABLET in 1 BOTTLE (76420-043-30) meloxicam Asclemed USA, Inc. 2020-08-27
76420-0043-60 60 TABLET in 1 BOTTLE (76420-043-60) meloxicam Asclemed USA, Inc. 2020-08-27
76420-0043-90 90 TABLET in 1 BOTTLE (76420-043-90) meloxicam Asclemed USA, Inc. 2020-08-27
76420-0325-00 1000 TABLET in 1 BOTTLE (76420-325-00) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0325-01 100 TABLET in 1 BOTTLE (76420-325-01) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0325-05 500 TABLET in 1 BOTTLE (76420-325-05) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0325-20 20 TABLET in 1 BOTTLE (76420-325-20) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0325-30 30 TABLET in 1 BOTTLE (76420-325-30) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0325-60 60 TABLET in 1 BOTTLE (76420-325-60) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0325-90 90 TABLET in 1 BOTTLE (76420-325-90) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0326-00 1000 TABLET in 1 BOTTLE (76420-326-00) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0326-01 100 TABLET in 1 BOTTLE (76420-326-01) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0326-05 500 TABLET in 1 BOTTLE (76420-326-05) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0326-20 20 TABLET in 1 BOTTLE (76420-326-20) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0326-30 30 TABLET in 1 BOTTLE (76420-326-30) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0326-60 60 TABLET in 1 BOTTLE (76420-326-60) MELOXICAM Asclemed USA, Inc. 2025-05-02
76420-0326-90 90 TABLET in 1 BOTTLE (76420-326-90) MELOXICAM Asclemed USA, Inc. 2025-05-02
80425-0041-01 30 TABLET in 1 BOTTLE (80425-0041-1) Meloxicam Advanced Rx of Tennessee, LLC 2007-03-07
80425-0041-02 60 TABLET in 1 BOTTLE (80425-0041-2) Meloxicam Advanced Rx of Tennessee, LLC 2007-03-07
Observed labelers: Proficient Rx LP (37) · Bryant Ranch Prepack (33) · PD-Rx Pharmaceuticals, Inc. (23) · Advanced Rx of Tennessee, LLC (22) · Asclemed USA, Inc. (18) · Terrain Pharmaceuticals, Inc. (14) · +31 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.